Аcute Coronary SyndromeSTOCSNCT06845384
Registry of Acute Coronary Syndrome in the Regional Cardiovascular Center
An observational study of Аcute Coronary Syndrome, run by National Medical Research Center for Therapy and Preventive Medicine at 1 site in Russia.
Trial summary
The study is a prospective registry of patients consequently admitted to the regional cardiovascular center with a diagnosis of acute coronary syndrome, in order to study the behavior of patients from the first minutes of the onset of the anginal syndrome, and influence of the delay in calling of ambulance on… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Аcute Coronary Syndrome
- How many people
- 555 participants
- Where
- 1 siteRussia
- Study dates
- 15 Jan 2025to 30 Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients consequently admitted to the regional cardiovascular center with a diagnosis of acute coronary syndrome, in order to study the behavior of patients from the first minutes of the onset of the anginal syndrome, and influence of the delay in calling of ambulance on short-term and long-term outcomes of the disease.
Who may be able to join
- Men and women aged 18 and over, permanently residing in the Moscow region and in Moscow.
- Patients hospitalized in the Regional Vascular Center of Stupino Clinical Hospital (GBUZ MO SKB) with a diagnosis of ACS with and without ST-segment elevation.
- Signing an informed consent form to participate in the study and the processing of personal data, as well as conducting a telephone survey during the follow-up.
Who cannot join
- The patient's refusal to participate in the study and to allow the use of personal data during the study.
- The presence of mental illness.
- The patient plans to leave Russia for permanent or long-term residence.
Trial locations and contacts
1 site in 1 country.
Russia1 site
National Medical Research Centre for Therapy and Preventive Medicine
Moscow, 101990
About this study
The study is a prospective registry of patients consequently admitted to the regional cardiovascular center with a diagnosis of acute coronary syndrome, in order to study the behavior of patients from the first minutes of the onset of the anginal syndrome, and influence of the delay in calling of ambulance on short-term and long-term outcomes of the disease. Other factors which may influence short-term and long-term outcomes will also be assessed.
- Conditions
- Аcute Coronary Syndrome
- Keywords
- acute coronary syndrome, percutaneous coronary intervention, unstable angina, acute myocardial infarction
- Medical subject headings
- Acute Coronary Syndrome, Angina, Unstable
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| No | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
all-cause mortality
Measured: 1 year and 3 years
Secondary outcomes (1)
Сombined secondary end-point
Rate of nonfatal myocardial infarction, nonfatal stroke, hospitalization for decompensated heart failure, and emergency invasive cardiac interventions.
Measured: 1 year and 3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Feb 2025
- Study start15 Jan 2025
- Primary completion30 Dec 2025
- Study completion30 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Аcute Coronary SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 555 participants (actual)
Sponsor and investigators
- Lead sponsor
- National Medical Research Center for Therapy and Preventive Medicine
- Sponsor type
- Other government
- Collaborators
- Stupino Clinical Hospital, Moscow Region State Medical Institution
- Responsible party
- Sponsor
- Investigators
- Sergey Martsevich, D.M., professor, Study director, National Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06845384
- Sponsor's protocol ID
- 03-06/24
- Acronym
- STOCS
- Status last verified
- May 2026
- First submitted
- 20 Feb 2025
- Last updated
- 19 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Registry of Acute Coronary Syndrome in the Regional Cardiovascular Center
- ClinicalTrials.gov ID
- NCT06845384
- Acronym / sponsor ID
- STOCS / 03-06/24
- Conditions
- Аcute Coronary Syndrome
- Keywords
- acute coronary syndrome, percutaneous coronary intervention, unstable angina, acute myocardial infarction
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 555 participants (actual)
- Lead sponsor
- National Medical Research Center for Therapy and Preventive MedicineOther government
- Collaborators
- Stupino Clinical Hospital, Moscow Region State Medical Institution
- Study start
- 15 Jan 2025 (actual)
- Primary completion
- 30 Dec 2025 (actual)
- Study completion
- 30 Dec 2025 (actual)
- First posted
- 25 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study is a prospective registry of patients consequently admitted to the regional cardiovascular center with a diagnosis of acute coronary syndrome, in order to study the behavior of patients from the first minutes of the onset of the anginal syndrome, and influence of the delay in calling of ambulance on short-term and long-term outcomes of the disease. Other factors which may influence short-term and long-term outcomes will also be assessed.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| No | – | – |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients consequently admitted to the regional cardiovascular center with a diagnosis of acute coronary syndrome, in order to study the behavior of patients from the first minutes of the onset of the anginal syndrome, and influence of the delay in calling of ambulance on short-term and long-term outcomes of the disease.
Key inclusion criteria (3 listed)
- Men and women aged 18 and over, permanently residing in the Moscow region and in Moscow.
- Patients hospitalized in the Regional Vascular Center of Stupino Clinical Hospital (GBUZ MO SKB) with a diagnosis of ACS with and without ST-segment elevation.
- Signing an informed consent form to participate in the study and the processing of personal data, as well as conducting a telephone survey during the follow-up.
Key exclusion criteria (3 listed)
- The patient's refusal to participate in the study and to allow the use of personal data during the study.
- The presence of mental illness.
- The patient plans to leave Russia for permanent or long-term residence.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
all-cause mortality
Time frame: 1 year and 3 years
1 secondary outcome
Сombined secondary end-point
Time frame: 1 year and 3 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2026.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sergey Martsevich, D.M., professor study director
National Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Аcute Coronary Syndrome, run by National Medical Research Center for Therapy and Preventive Medicine at 1 site in Russia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
all-cause mortality (time frame: 1 year and 3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.